利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

4 条记录 (耗时 0.021 秒)

    Cyclipostins, process for their preparation and use thereof
    3.
    发明授权
    Cyclipostins, process for their preparation and use thereof 有权
    Cyclipostins，其制备和使用的方法

    公开(公告)号：US06756402B2

    公开(公告)日：2004-06-29

    申请号：US09886044

    申请日：2001-06-22

    申请人： Laszlo Vertesy ,  Klaus Ehrlich ,  Michael Kurz ,  Joachim Wink

    发明人： Laszlo Vertesy ,  Klaus Ehrlich ,  Michael Kurz ,  Joachim Wink

    IPC分类号： A61K31335

    CPC分类号： C12R1/465 ,  C07F9/65744 ,  C12P9/00

    摘要： The invention relates to compounds of formula I in which R1, R2, E, X1, X2, and X3 have the meaning as described in the specification and claims, obtained by culturing Streptomyces species HAG 004107 (DSM 13381), and their physiologically tolerable salts and chemical equivalents. The invention furthermore relates to a process for the preparation of the cyclipostins, the microorganism HAG 004107 (DSM 13381), the use of the cyclipostins and their physiologically tolerable salts and chemical equivalents as pharmaceuticals, in particular as inhibitors of lipases, and pharmaceutical preparations which contain cyclipostin or a physiologically tolerable salt or equivalent thereof.

    摘要翻译： 本发明涉及式Iin化合物，其中R 1，R 2，E，X 1，X 2和X 3具有如说明书和权利要求书中所述的含义，通过培养链霉菌种类HAG 004107（DSM 13381）， 及其生理上可耐受的盐和化学当量。 本发明还涉及一种制备环肽酶，微生物HAG 004107（DSM 13381），环肽素及其生理上可耐受的盐和化学等价物作为药物，特别是作为脂肪酶抑制剂的药物制剂的方法，以及药物制剂 含有Cycipostin或生理上可耐受的盐或其等同物。

    Pluraflavins and derivatives thereof, process for their preparation and use thereof
    4.
    发明授权
    Pluraflavins and derivatives thereof, process for their preparation and use thereof 有权
    多夫肝素及其衍生物，其制备方法和用途

    公开(公告)号：US06500936B2

    公开(公告)日：2002-12-31

    申请号：US09784035

    申请日：2001-02-16

    申请人： Laszlo Vertesy ,  Klaus Ehrlich ,  Martin Knauf ,  Joachim Wink ,  Francis P. Barbone ,  Elaine A. Powers ,  Elizabeth A. Cashman

    发明人： Laszlo Vertesy ,  Klaus Ehrlich ,  Martin Knauf ,  Joachim Wink ,  Francis P. Barbone ,  Elaine A. Powers ,  Elizabeth A. Cashman

    IPC分类号： A61K3135

    CPC分类号： C12R1/01 ,  C07H17/04 ,  C12P19/26 ,  C12P19/60

    摘要： The invention relates to a compound of formula (I) wherein R1 is a sugar; R2 is —CH2—O—(R7)m, R7 representing a sugar, or is —COOH; R3 is an epoxide-comprising group, or is C1-C6-alkyl or C2-C6-alkenyl, unsubstituted or substituted by at least one OH; R5 is H, C1-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl; R4R6, R8 and R10 independently of one another are H; C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, —X2H, or —X2R12, or R4 and R6 together and/or R8 and R10 together are =X2; X2 is O, NH, N—C1-C6-alkyl, N—C2-C6-alkenyl, N-C2-C6-alkynyl or S; R12 is C1-C6-alkyl, C2-C6—alkenyl, C2-C6-alkynyl, aryl or acyl; and m and n are 1 or 2; in any of its stereochemical forms and mixtures of these forms in any ratio, and a physiologically acceptable salt or derivative thereof. The compounds are obtainable from a culture of the microorganism Actinomycetales species HAG 003959, DSM 12931, by fermentation. Accordingly, the invention relates to a process for their preparation and to the use of the compounds as pharmaceuticals, for example as antitumor agents.

    摘要翻译： 本发明涉及式（I）化合物，其中R1是糖; R2是-CH2-O-（R7）m，R7代表糖，或是-COOH; R3是含环氧化物的基团，或是未被取代或被至少一个OH取代的C1-C6-烷基或C2-C6-烯基; R5是H，C1-C6-烷基，C2-C6-烯基或C2-C6-炔基; R4R6，R8和R10彼此独立地为H; C1-C6-烷基，C2-C6-烯基，C2-C6-炔基，-X2H或-X2R12或R4和R6一起和/或R8和R10一起为= X2; X 2是O，NH，N-C 1 -C 6 - 烷基，N-C 2 -C 6 - 烯基，N-C 2 -C 6 - 炔基或S; R 12是C 1 -C 6烷基，C 2 -C 6 - 烯基，C 2 -C 6炔基，芳基或酰基; m和n为1或2; 其任何立体化学形式和这些形式的任何比例的混合物及其生理上可接受的盐或其衍生物。 这些化合物可通过发酵从放线菌种类HAG 003959，DSM 12931的培养物中获得。 因此，本发明涉及其制备和使用化合物作为药物的方法，例如作为抗肿瘤剂。